QRX-1011

N/A

Report date: 2023/09/26 16:26:59
NME

Base Information

Drug NameQRX-1011
Drug Alias NameQRX-1011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinal-specific phospholipid-transporting ATPase ABCA4 replacements
TargetsRetinal-specific phospholipid-transporting ATPase ABCA4
Therapy Area/IndicationsStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProqr Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesProqr Therapeutics
Inactive CompaniesN/A
Active IndicationsStargardt Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A